A common theme during this year’s summit was the uncertainty about the profitability of the existing specialty pharmaceutical model.
Thomas Cohn, Chief Strategy Officer, Asembia
Advertisement
Articles by Thomas Cohn, Chief Strategy Officer, Asembia
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
Trump Executive Order Recommends Separating MMR Into 3 Shots
2
GLP-1s: A New Frontier in Substance Use Disorder Management
3
First-in-Class RNA Degrader Targets Historically ‘Undruggable’ MYC in Preclinical Multiple Myeloma Models
4
Suzetrigine-Based Multimodal Therapy Enables Opioid-Free Recovery in Patients Receiving Surgery
5